Last month, when Optimi Health kicked off an initial public offering of 2.5 million shares, the timing couldn’t have been better for the Vancouver-based manufacturer of psychedelic drugs. With President Donald Trump recently signing an executive order to accelerate research and ease the restrictions on psychedelics, there is unprecedented buzz around the potential of the hallucinogenic drugs to treat mental disorders.
The timing is right for psychedelics manufacturer Optimi Health’s IPO
Latest from Blog
UNC Nutrition Obesity Research Center awarded $5.8M NIH renewal through 2031 – UNC Gillings School of Global Public Health
September 18, 2026 The Center brings together clinicians, public health researchers, basic and behavioral scientists, and others who share a common goal of advancing nutrition and obesity research from infancy through older adulthood. Post Views: 3
Brightcore Nutrition
News Channel 3 – Memphis, TN News, Sports and Weather Post Views: 4
Why your hair, nails, and skin are the first clues of a nutrition gap on Ozempic
A peer reviewed review coauthored by a Beverly Hills surgeon argues the hollowed look from rapid GLP-1 weight loss is partly a nutrition problem, and one you can do something about. Post
Quality nutrition for a quality life
WFLA News Channel 8 On Your Side in Tampa Bay Florida Post Views: 4
‘Fully compliant’: Nestlé India responds to FSSAI action over infant nutrition products
Nestlé India on Friday said its infant nutrition products are fully compliant with applicable regulations, responding to legal action initiated by the Food Safety and Standards Authority of India (FSSAI) over promotional